Clinical phenotype of AAV, anti-GBM disease and double-positive patients after SARS-CoV-2 vaccination

IF 9.2 1区医学 Q1 IMMUNOLOGY

Autoimmunity reviews Pub Date : 2024-03-13 DOI:10.1016/j.autrev.2024.103521

Yisha Li , Jie Wang , Shuang Liang, Yan Zhang, Zhe Feng, Guangyan Cai

引用次数: 0

Abstract

The number of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV), anti-glomerular basement membrane (GBM) disease and double-positive patients (DPPs) following the coronavirus disease 2019 (COVID-19) vaccine reported in the literature is increasing, we reviewed the reported cases of AAV, anti-GBM disease and DPPs subsequent to COVID-19 vaccination, and compared the disparities in DPPs who received the COVID-19 vaccination and those who did not. We did not observe any differences in clinical phenotype of AAV, anti-GBM disease and DPPs before and after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination.

查看原文本刊更多论文

接种 SARS-CoV-2 疫苗后 AAV、抗 GBM 疾病和双阳性患者的临床表型。

文献中报道的接种冠状病毒病2019（COVID-19）疫苗后出现抗中性粒细胞胞浆抗体（ANCA）相关性血管炎（AAV）、抗肾小球基底膜（GBM）病和双阳性患者（DPPs）的数量正在增加，我们回顾了接种COVID-19疫苗后出现AAV、抗GBM病和DPPs的报道病例，并比较了接种COVID-19疫苗和未接种COVID-19疫苗的DPPs的差异。我们没有观察到接种严重急性呼吸系统综合症冠状病毒 2（SARS-CoV-2）疫苗前后 AAV、抗 GBM 病和 DPP 的临床表型有任何差异。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Autoimmunity reviews 医学-免疫学

CiteScore

24.70

自引率

4.40%

发文量

164

审稿时长

21 days

期刊介绍： Autoimmunity Reviews is a publication that features up-to-date, structured reviews on various topics in the field of autoimmunity. These reviews are written by renowned experts and include demonstrative illustrations and tables. Each article will have a clear "take-home" message for readers. The selection of articles is primarily done by the Editors-in-Chief, based on recommendations from the international Editorial Board. The topics covered in the articles span all areas of autoimmunology, aiming to bridge the gap between basic and clinical sciences. In terms of content, the contributions in basic sciences delve into the pathophysiology and mechanisms of autoimmune disorders, as well as genomics and proteomics. On the other hand, clinical contributions focus on diseases related to autoimmunity, novel therapies, and clinical associations. Autoimmunity Reviews is internationally recognized, and its articles are indexed and abstracted in prestigious databases such as PubMed/Medline, Science Citation Index Expanded, Biosciences Information Services, and Chemical Abstracts.